Today at Berkeley Lab

World Economic Forum Honors Lab Startup

Lab startup Second Genome was named a 2017 World Economic Forum Technology Pioneer, one of 30 early stage companies around the world anticipated to have a significant effect on business and society. Second Genome applies its proprietary microbiome platform to drug discovery and development. The startup’s current focus is the treatment of inflammatory bowel disease (IBD).

You can leave a comment. View the Comment Policy.

Leave a Reply